Syndax Pharmaceuticals Inc. logo

Syndax Pharmaceuticals Inc.

SNDX | NASDAQ
Chart Builder DCF Calculator
$18.20
+$0.13 (+0.72%)
Sep 22, 2026, 2:16 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-285.42M -318.76M -209.36M -149.34M 24.93M -73.16M
Depreciation & Amortization
6K 8K 12K 33K 43K 89K
Stock-Based Compensation
47.5M 43.03M 30.95M 16.02M 13.32M 9.06M
Other Working Capital
-15.35M 23.21M 15.54M 2.98M -11.76M -5.26M
Other Non-Cash Items
-5.75M -12.45M -14.06M -2.05M 187K 686K
Deferred Income Tax
n/a n/a n/a n/a 255K n/a
Change in Working Capital
-79.32M 13.27M 31.86M 1.66M -9.6M -7.93M
Operating Cash Flow
-322.98M -274.9M -160.6M -133.68M 29.13M -71.26M
Capital Expenditures
-187K n/a n/a -225K -129K n/a
Cash Acquisitions
n/a n/a n/a 225K 40.74K n/a
Purchase of Investments
-195.81M -557.05M -354.61M -495.35M -294.72M -278.94M
Sales Maturities Of Investments
486.03M 337.28M 472.22M 308.93M 253.98M 136.41M
Other Investing Acitivies
n/a n/a n/a 225K -40.74K n/a
Investing Cash Flow
290.04M -219.78M 117.61M -186.19M -40.87M -142.53M
Debt Repayment
n/a n/a n/a -21M n/a 19.73M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 343.65M 6.04M 11.86M 32.13M 6.63M
Financial Cash Flow
13.68M 353.37M 264.13M 172.25M 118.46M 304.42M
Net Cash Flow
-19.27M -141.31M 221.14M -147.61M 106.72M 90.63M
Free Cash Flow
-323.17M -274.9M -160.6M -133.9M 29M -71.26M
Adj. Free Cash Flow
-370.67M -317.93M -191.55M -149.92M 15.69M -80.32M
Maintenance CapEx
n/a n/a n/a -225K n/a n/a
Growth CapEx
-187K n/a n/a n/a -129K n/a
Owner Earnings
-322.98M -274.9M -160.6M -133.9M 29.13M -71.26M

© 2026 bestshares.com. All rights reserved.